Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study marzo 12, 2022enero 6, 2023
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression febrero 25, 2016octubre 7, 2022
Effects of brain asymmetry on clinical manifestations and quality of life in Parkinson´s disease octubre 25, 1920octubre 25, 2022
Changes in principal caregiver mood affects the mood of the Parkinson disease patient. The vicious cycle of illness. diciembre 27, 1919enero 25, 2023
Risk of Cognitive Impairment in Parkinson´s Disease Patients with Visual Hallucinations and Subjective Cognitive Complaints. diciembre 27, 1919enero 25, 2023
Clinical and structural brain correlates of hypomimia in early-stage Parkinson’s disease. diciembre 27, 1919diciembre 27, 2022
Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson’s disease patients. diciembre 27, 1919diciembre 27, 2022
Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study diciembre 27, 1919diciembre 27, 2022
Increased homocysteine levels correlate with cortical structural damage in Parkinson’s disease. Increased homocysteine levels correlate with cortical structural damage in Parkinson’s disease. diciembre 27, 1919diciembre 27, 2022
Parkinson’s Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up diciembre 27, 1919diciembre 27, 2022
